sinc
emerg
sever
acut
respiratori
syndrom
sar
date
neither
effect
antivir
drug
vaccin
sar
avail
howev
found
mixtur
two
proteinas
inhibitor
lopinavir
ritonavir
exhibit
sign
effect
sar
viru
understand
fine
detail
molecular
interact
proteinas
inhibitor
sar
viru
via
complex
molecular
dynam
simul
carri
sarscov
pro
free
enzym
free
sar
complex
lopinavir
sarslpv
ritonavir
sarsrtv
result
show
flap
close
clearli
observ
inhibitor
bind
activ
site
sarscov
pro
bind
affin
lpv
rtv
sarscov
pro
show
signific
differ
addit
six
hydrogen
bond
detect
sarslpv
system
seven
hydrogen
bond
found
sarsrtv
complex
report
first
guangdon
provinc
china
late
atyp
pneumonia
sever
acut
respiratori
syndrom
sar
concern
sinc
subsequ
rapidli
spread
countri
display
estim
mortal
rate
infect
human
lead
human
death
donnelli
et
al
march
four
month
first
case
report
caus
agent
sar
identifi
new
coronaviru
cov
kuiken
et
al
peiri
et
al
complet
genom
sequenc
nucleotid
ssrna
viru
report
month
later
marra
et
al
provid
opportun
indepth
studi
identif
potenti
target
drug
vaccin
develop
genom
sarscov
contain
major
annot
open
read
frame
includ
predict
encod
known
viral
protein
includ
replicas
polyprotein
spike
protein
polymeras
membran
protein
n
nucleocapsid
protein
e
small
envelop
protein
viral
proteinas
replicas
prefer
target
search
design
antivir
compound
inde
sarscov
main
proteinas
pro
also
call
pro
exhibit
key
role
proteolyt
process
replicas
polyprotein
essenti
protein
viral
replic
function
view
key
target
whilst
phylogenet
analysi
sar
genom
reveal
littl
resembl
three
known
group
cornoavirus
sever
specif
viral
gene
includ
main
proteas
gene
sarscov
pro
show
signific
homolog
thu
sequenc
align
sarscov
pro
orthologu
coronavirus
indic
enzym
highli
conserv
sequenc
ident
respect
human
cov
hcov
proteinas
procin
transmiss
gastroenter
viru
tgev
proteinas
crystal
structur
pro
protein
determin
hsu
et
al
lee
et
al
reveal
similar
cov
proteinas
sarscov
pro
form
homodim
compris
three
domain
domain
residu
ii
residu
bbarrel
togeth
resembl
structur
chymotrypsin
respect
wherea
domain
iii
residu
consist
mainli
ahelic
domain
ii
iii
connect
long
loop
residu
activ
site
pro
compris
catalyt
dyad
consist
conserv
residu
locat
cleft
domain
ii
huang
et
al
avail
protein
structur
known
biolog
characterist
pro
encourag
help
facilit
key
target
search
drug
direct
sar
although
neither
effect
antivir
drug
vaccin
sar
current
avail
sever
report
indic
proteas
inhibitor
potenti
design
sarscov
proteinas
inhibitor
zhang
yap
yamamoto
et
al
jenwitheesuk
samudrala
particular
proteinas
inhibitor
kaletra
mixtur
proteinas
inhibitor
lopinavir
ritonavir
fig
exhibit
encourag
sign
partial
effect
sar
viru
vastag
therefor
deeper
understand
known
proteinas
inhibitor
antisar
drug
use
start
point
design
discov
better
specif
inhibitor
treatment
sar
well
mutat
predict
resist
mechan
andor
new
drug
mechan
advanc
present
research
evid
potenti
benefit
proteas
inhibitor
sar
coronaviru
sarscov
provid
molecular
dynam
simul
perform
order
investig
structur
dynam
behaviour
free
enzym
complex
lopinavir
ritonavir
inhibitor
order
understand
ligandenzym
interact
well
effect
inhibitor
structur
dynam
properti
free
enzym
three
molecular
dynam
md
simul
perform
sarscov
pro
free
enzym
free
sar
two
complex
lopinavir
sarslpv
ritonavir
sarsrtv
inhibitor
xray
structur
sarscov
pro
pdb
code
resolut
use
initi
model
construct
sarsrtv
sarslpv
complex
fig
prior
simul
residu
visibl
electron
densiti
map
model
use
leap
modul
amber
softwar
packag
case
et
al
model
conform
begin
simul
similar
residu
polypeptid
chain
dimer
exhibit
welldefin
electron
densiti
flexibl
molecular
dock
muegg
martin
genet
algorithm
perform
use
biomedcach
softwar
find
favor
bind
interact
two
drug
ritonavir
lopinavir
separ
dock
sarscov
pro
bind
site
residu
associ
bind
pocket
defin
conserv
amino
acid
residu
name
also
known
part
catalyt
site
sarscov
proteinas
anand
et
al
yang
et
al
addit
neighbor
residu
within
radiu
conserv
amino
acid
select
consid
member
bind
pocket
structur
sarscov
pro
obtain
xray
crystallograph
structur
pdb
miss
hydrogen
atom
ad
enzym
use
tleap
amber
simul
packag
geometri
inhibitor
gener
xray
structur
hydrogen
atom
ad
use
use
antechamb
assign
atom
type
geometri
inhibitor
optim
semiempir
method
pmf
score
drug
evalu
genet
algorithm
popul
size
crossov
rate
elit
mutat
rate
maximum
gener
cycl
set
size
grid
box
set
sinc
expect
signific
differ
found
term
orient
among
complex
structur
within
lowenergi
cluster
conform
lowest
pmf
energi
score
use
initi
model
md
simul
final
complex
structur
lowest
pmf
energi
score
construct
use
initi
model
md
simul
three
md
simul
free
sar
sarsrtv
sarslpv
carri
use
amber
simul
packag
energi
minim
md
simul
achiev
use
sander
modul
amber
cornel
forc
field
cornel
et
al
forc
field
describ
structur
conform
compound
appli
md
run
report
achiev
isobaricisotherm
ensembl
npt
use
constant
pressur
atm
constant
temperatur
k
shake
algorithm
ryckaert
et
al
use
constrain
bond
involv
hydrogen
atom
energi
minim
carri
relax
system
prior
md
run
incorpor
solvent
counter
ion
model
system
neutral
counter
ion
na
solvat
water
model
jorgensen
et
al
total
number
atom
three
simul
system
free
sar
sarslpv
sarsrtv
respect
crystallograph
water
also
kept
simul
box
simul
time
step
set
femtosecond
fs
simul
step
consist
thermal
equilibr
product
phase
initi
temperatur
system
gradual
rais
k
first
picosecond
ps
kept
constant
accord
berendsen
algorithm
coupl
time
ps
system
maintain
k
ps
final
product
phase
start
ps
ns
ps
trajectori
product
phase
use
calcul
averag
structur
md
simul
carri
ns
qualiti
geometri
stereochemistri
protein
structur
valid
use
procheck
md
trajectori
evalu
term
rootmeansquar
displac
rmsd
chang
distanc
torsion
angl
hbond
bind
free
energi
use
carnal
ptraj
mmpbsa
modul
simul
packag
ns
md
trajectori
three
simul
system
gener
rmsd
overal
structur
two
inhibitor
respect
initi
configur
analyz
plot
fig
overal
rmsd
three
system
appear
reach
equilibrium
ps
whilst
signific
differ
found
overal
black
back
bone
dark
grey
rmsd
plot
rtv
sarsrtv
complex
light
grey
found
chang
substanti
due
rotat
rtv
sarscov
pro
pocket
ie
initi
dock
conform
rtv
total
differ
equilibr
protein
flexibl
essenti
understand
ligandbind
affin
carlson
carlson
mccammon
lin
et
al
teagu
conform
chang
catalyt
bind
domain
play
critic
role
ligand
bind
ligandbind
site
sarscov
pro
evalu
focus
amino
acid
sequenc
around
activ
site
see
fig
cov
proteinas
anand
et
al
yang
et
al
bind
inhibitor
like
affect
rel
motion
apex
loop
respect
loop
upon
insert
inhibitor
probabl
distribut
associ
interatom
distanc
center
mass
follow
residu
three
system
evalu
plot
fig
clearli
sarscov
pro
show
differ
dynam
flexibl
bind
region
sarsselect
inhibitor
bound
activ
site
sarscov
pro
free
enzym
probabl
distanc
take
place
contract
enzymeinhibitor
complex
distanc
loop
region
signific
differ
observ
free
enzym
two
enzymeinhibitor
complex
rather
optim
distanc
repres
maximum
plot
sarscov
pro
two
inhibitor
complex
fig
could
due
fact
sarscov
pro
free
form
initi
gener
complex
sarscov
pro
structur
identifi
close
loop
conform
similarli
kind
flap
loop
close
also
observ
inhibitor
bind
activ
site
proteas
hornak
et
al
b
addit
sarsrtv
distribut
plot
narrow
higher
sarslpv
indic
lower
flexibl
catalyt
pocket
flap
loop
sarsrtv
complex
compar
sarslpv
complex
fact
relat
directli
greater
flexibl
longer
side
chain
rtv
lpv
anoth
structur
featur
common
enzymeinhibitor
complex
gener
conform
enzymebind
site
investig
enzymebind
site
conform
sarscov
pro
analyz
chang
four
dihedr
angl
key
interact
enzym
involv
amino
acid
catalyt
residu
tip
loop
upon
inhibitor
insert
studi
present
conform
analysi
two
torsion
angl
catalyt
residu
cacbcgcd
ncacb
two
amino
acid
tip
loop
cacbcgod
cbcgcdca
ps
simul
summar
fig
tabl
free
form
gener
sharp
peak
indic
rigid
side
chain
howev
case
side
chain
show
broad
peak
rang
contrast
residu
gener
two
peak
repres
two
preferenti
conform
chang
conform
due
complex
format
clearli
observ
four
residu
orient
repres
respect
side
chain
rotat
via
complex
format
direct
inhibitor
contrast
side
chain
induc
rtv
lpv
turn
opposit
side
increas
rtv
complex
dot
line
fig
whilst
first
peak
decreas
lpv
complex
dash
line
fig
sarslpv
sarsrtv
interact
analyz
use
hydrogen
bond
interact
molecular
mechan
energi
obtain
electrostat
van
der
waal
interact
within
system
result
summar
tabl
analyz
hydrogen
bond
interact
percentag
occup
number
hydrogen
bond
inhibitor
bind
pocket
residu
determin
base
follow
criteria
proton
donoracceptor
distanc
ii
donorhacceptor
bond
angl
found
number
hydrogen
bond
two
system
almost
compar
tabl
six
hydrogen
bond
detect
sarslpv
system
whilst
seven
found
sarsrtv
complex
howev
hydrogen
bond
show
rather
low
occup
interestingli
exclud
two
inhibitor
found
form
hydrogen
bond
differ
residu
rtv
bind
lpv
bind
term
gasphas
mm
interact
energi
de
mm
summar
tabl
molecular
mechan
interact
energi
sarslpv
complex
kcalmol
lower
sarsrtv
complex
kcalmol
take
account
hydrophob
electrostat
interact
mm
interact
energi
higher
contribut
van
der
waal
energi
kcalmol
lower
contribut
electrostat
energi
kcalmol
observ
sarslpv
complex
sarsrtv
complex
averag
bind
free
energi
dg
bind
two
complex
shown
tabl
studi
contribut
entrop
term
td
exclud
due
reason
previou
work
two
system
model
similar
therefor
contribut
td
dg
bind
term
rel
scale
neglig
result
total
electrostat
contribut
term
dg
ele
sol
de
ele
sarsrtv
kcalmol
found
favor
sarslpv
kcalmol
understood
higher
polar
rtv
side
chain
lpv
howev
van
der
waal
interact
nonpolar
solvat
term
sarsrtv
complex
unfavor
kcalmol
rel
sarslpv
complex
sum
contribut
total
bind
free
energi
sarslpv
complex
slightli
favor
sarsrtv
complex
kcalmol
respect
close
similar
kcalmol
differ
due
structur
similar
complex
inde
inher
suggest
bind
affin
lpv
rtv
significantli
differ
sarscov
pro
enzym
accord
fact
lpv
inhibitor
develop
rtv
structur
inhibit
quit
similar
ligand
solvat
especi
catalyt
pocket
known
play
essenti
role
catalyt
mechan
enzym
ascertain
basic
inform
ligand
solvat
radial
distribut
function
rdf
g
ij
r
probabl
find
particl
type
spheric
radii
r
around
particl
type
jcenter
select
atom
inhibitor
calcul
evalu
done
separ
atom
set
inhibitor
lay
either
equival
ii
differ
environ
see
fig
atom
label
result
summar
fig
two
complex
central
part
enzymeinhibitor
complex
caviti
atom
two
inhibitor
topolog
equival
fig
plot
show
pronounc
first
peak
indic
three
atom
tightli
solvat
water
molecul
addit
three
plot
sarsrtv
complex
dash
line
show
lower
minima
indic
resid
time
first
shell
solvat
sarsrtv
complex
longer
sarslpv
one
contrast
atom
inhibitor
solvat
significantli
lower
extent
impli
high
hydrophil
around
region
outer
part
inhibitor
see
also
fig
rdf
given
fig
sarsrtv
complex
dash
line
sarslpv
complex
solid
line
firmli
solvat
exclud
two
region
two
end
two
inhibitor
much
less
solvat
first
peak
broad
locat
far
refer
atom
indic
highli
hydrophob
characterist
two
drug
molecul
md
simul
analysi
free
sar
sarsrtv
sarslpv
complex
give
insight
dynam
characterist
term
flexibl
conform
inhibitorenzym
interact
analysi
energet
bind
affin
proteinas
inhibitor
extens
perform
base
free
energi
calcul
found
interact
lpv
rtv
show
signific
differ
sarscov
pro
enzym
